AzTrials
AzTrials

Percutaneous Coronary InterventionNCT06445387

Pain During Femoral Sheath Removal in Patients Undergoing Percutaneous Coronary Intervenion

A study testing Virtual Reality Glasses and Ice Application Group in people with Percutaneous Coronary Intervention and Virtual Reality, run by Amasya University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is to examine the effect of virtual reality and ice application on the pain level due to femoral sheath extraction. Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
Virtual Reality Glasses and Ice Application Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
108 participants
Where
1 siteTurkey (Türkiye)
Study dates
12 Jul 2021to 4 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Intervention in the femoral region,
  • Femoral sheath size is 6-7 fr,
  • Presence of only one sheath in the femoral region,
  • No analgesics were administered before femoral sheath removal,
  • Absence of serious bleeding and major hematoma in the femoral region,
  • Being over 18 years of age,
Show all 13Show fewer
  • No communication problems,
  • Having a place and time orientation,
  • No dizziness,
  • Not having any psychiatric disease,
  • No visual, auditory or mental problems,
  • No previously identified cold allergy,
  • Being willing and willing to participate in the study,

Who cannot join

  • Serious bleeding and major hematoma development in the femoral region,
  • Not applying intracoronary stent or coronary angioplasty after coronary angiography,
  • Vital signs are abnormal enough to prevent intervention,
  • Having visual, auditory and mental disabilities,
  • Having a communication problem,
  • Not being willing and able to participate in the study,
  • It is defined as wanting to withdraw from the study at any stage of the study or being excluded from the study by the researcher.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Amasya University İnstitute of Health Sciences

    Amasya, Merkez, 05100

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Virtual Reality Glasses and Ice Applıcatıon on the Level of Pain During Femoral Sheath Removal in Patients Undergoing Percutaneous Coronary Intervenion

It is to examine the effect of virtual reality and ice application on the pain level due to femoral sheath extraction.

Read the detailed description

After obtaining the necessary permissions for the research, the patients who were followed up in the hemodialysis unit of X,Y, Z Hospitals were randomly divided into three groups (virtual reality glasses application, ice application and control group).

Randomization: Since the number of male and female patients was wanted to be kept equal, simple randomization would not be possible, so the stratified randomization method was used.

Patients were assigned to groups in equal numbers according to their femoral sheath sizes. In our clinic, size 6 and 7 femoral sheaths are applied to male patients, and number 6 femoral sheaths are applied to female patients. Male patients were assigned to equal groups according to femoral sheath size 6 and 7.

Since PCI is not performed in our clinic on weekends except for emergencies, data were collected during working hours during a five-day weekday period.

The pain level of the patients was evaluated using a numerical rating scale;

  • before the femoral sheath extraction (PAS1),
  • during the femoral sheathing (SDQ2),
  • immediately after the femoral sheathing (SDQ3),
  • 30 minutes after the femoral sheathing (SDQ4) and
  • 1 hour after the femoral sheathing (SDQ4). SDÖ5) was evaluated and recorded.
Being tested
Virtual Reality Glasses, Ice Application Group, Control Group
Keywords
Percutaneous Coronary Intervention, Virtual Reality, Pain Management, Nursing, Ice Application
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality GlassesOther

    Also called Experimental

    Preparation Stage of Virtual Glasses: A 20-minute video consisting of nature scenes shot with a 360-degree camera was selected by the researchers from YouTube. Permission was obtained from the person who created the video.

    For the selection of music, both the music that is good for diseases were examined in the literature and an expert opinion was taken from a faculty member (Phd, assistant professor) working at the Faculty of Music and Fine Arts of a university. The music used in the video was created with works selected from the Hüseyni maqam.

  • Ice Application GroupOther

    Also called Experimental

    Features of the ice and ice bag used for patients in ice application; Ice cubes with dimensions of 9.5 x 26 x 3.5 cm were used. The ice bag is made of cotton and polyester coated fabric and is easily bendable. In this way, the ice bag was ensured to fit properly to the patient's femoral region. It is reusable and heat insulated. The procedure was carried out by following the cold application step protocol created by the researchers using the literature.

  • Control GroupOther

    Also called Control

    They continued to receive their routine treatment and care. No changes were made in their routine treatment and care.

Study groups in NCT06445387
Study groupRoleWhat they receive
Virtual Reality Glasses GruopExperimentalThe procedure was tested for five minutes, one hour before application, to evaluate the patients' compliance and to detect any possible problems after wearing the glasses. In patients who did not experience any problems after the test, glasses were put on the patient just before the femoral sheath and remained on for 20 minutes.
Receives: Other: Virtual Reality Glasses
Ice Application GroupExperimentalBefore taking the femoral sheath, the researcher applied cold to the area where the femoral sheath was located with an ice pack for 20 minutes. A femoral sheath was performed immediately after the ice bag was removed.
Receives: Other: Ice Application Group
Control GroupOtherThe general procedure of the clinic was applied to the control group. Femoral sheath was removed without any invasive procedure.
Receives: Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Scores: Numerical rating scale

    The Numeric Rating Scale is a pain screening tool, commonly used to assess pain severity at that moment in time using a min:0-max:10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable" (10). This scale is a valid and reliable scale developed to determine the pain level of patients. The numerical rating scale simplifies the description of the pain level by the patient and makes it easier for the monitoring nurse to record the patient's pain rating. That the pain increases as the score increases, and then the patient verbally tells the numerical value of the pain intensity he/she feels. Pain score was measured before femoral sheath removal (time 1), and, during femoral sheath removal (2nd time),and, immediately after femoral sheath removal (3rd time), and 30 minutes after femoral sheath removal (4th time), and1 hour after femoral sheath removal (5th time).

    Measured: "through study completion, an average of 1 year".

Secondary outcomes (4)
  1. Physiological parameter

    Vital parameters (Pulse rate measured in minutes) of the patients were evaluated

    Pulse rate was measured before femoral sheath removal (time 1) Pulse rate was measured during femoral sheath removal (2nd time) Pulse rate was measured immediately after femoral sheath removal (3rd time) Pulse rate was measured 30 minutes after femoral sheath removal (4th time) Pulse rate was measured 1 hour after femoral sheath removal (5th time

    Measured: "through study completion, an average of 1 year".

  2. Physiological parameter

    Vital parameters (respiration-rate measured in minutes) of the patients were evaluated.

    Respiration rate was measured before femoral sheath removal (time 1) Respiration rate was measured during femoral sheath removal (2nd time) Respiration rate was measured immediately after femoral sheath removal (3rd time) Respiration rate was measured 30 minutes after femoral sheath removal (4th time) Respiration rate was measured 1 hour after femoral sheath removal (5th time)

    Measured: "through study completion, an average of 1 year".

  3. Physiological parameter

    Vital parameters (blood pressure-measured in mmHg) of the patients were evaluated

    Blood pressure was measured before femoral sheath removal (time 1) Blood pressure was measured during femoral sheath removal (2nd time) Blood pressure was measured immediately after femoral sheath removal (3rd time) Blood pressure was measured 30 minutes after femoral sheath removal (4th time) Blood pressure was measured 1 hour after femoral sheath removal (5th time)

    Measured: "through study completion, an average of 1 year".

  4. Physiological parameter

    Vital parameters (body temperature measured in degrees Centigrant) of the patients were evaluated

    Body temperature was measured before femoral sheath removal (time 1) Body temperature was measured during femoral sheath removal (2nd time) Body temperature was measured immediately after femoral sheath removal (3rd time) Body temperature was measured 30 minutes after femoral sheath removal (4th time) Body temperature was measured 1 hour after femoral sheath removal (5th time)

    Measured: "through study completion, an average of 1 year".

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2024
  2. Study start12 Jul 2021
  3. Primary completion3 Nov 2022
  4. Study completion4 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
It is a randomized controlled, single-blind, experimental study. Participants were assigned to three groups: intervention (virtual reality group and ice group) and control group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
108 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06445387
Sponsor's protocol ID
AU-SBE-ASoylu-03
Status last verified
May 2024
First submitted
16 May 2024
Last updated
6 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: starting in December 2025 Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR)

Publications

  • Wang HL, Keck JF. Foot and hand massage as an intervention for postoperative pain. Pain Manag Nurs. 2004 Jun;5(2):59-65. doi: 10.1016/j.pmn.2004.01.002.

    PubMed 15297952
  • Paice JA, Cohen FL. Validity of a verbally administered numeric rating scale to measure cancer pain intensity. Cancer Nurs. 1997 Apr;20(2):88-93. doi: 10.1097/00002820-199704000-00002.

    PubMed 9145556

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Glasses and Ice Application Group in people with Percutaneous Coronary Intervention and Virtual Reality, run by Amasya University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Scores: Numerical rating scale (time frame: "through study completion, an average of 1 year".). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06445387, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in